KERALA AYURVEDA
Back to Balance Sheet
|
KERALA AYURVEDA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-4.78 Cr | ₹0.18 Cr | ₹-0.70 Cr | ₹-0.20 Cr | ₹-0.61 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of KERALA AYURVEDA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-4.78 Cr |
| Mar2024 | ₹0.18 Cr |
| Mar2023 | ₹-0.70 Cr |
| Mar2022 | ₹-0.20 Cr |
| Mar2021 | ₹-0.61 Cr |
How is Deferred Tax Assets / Liabilities of KERALA AYURVEDA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-4.78 Cr | Negative | |
| Mar2024 | ₹0.18 Cr | Positive | |
| Mar2023 | ₹-0.70 Cr | Negative | |
| Mar2022 | ₹-0.20 Cr | Negative | |
| Mar2021 | ₹-0.61 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of KERALA AYURVEDA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KERALA AYURVEDA | ₹201.5 Cr | -6.5% | -15% | -72% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,711.0 Cr | 1.1% | 4.6% | 14.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,376.0 Cr | 0.6% | 8.3% | 8.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,655.0 Cr | 6.3% | 12.2% | 45.5% | Stock Analytics | |
| CIPLA | ₹113,979.0 Cr | -1.7% | -2.8% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,204.7 Cr | -3.7% | -10.4% | -6% | Stock Analytics | |
KERALA AYURVEDA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KERALA AYURVEDA | -6.5% |
-15% |
-72% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses